● Recruiting

SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009)

Condition: Carcinoma, Non-Small-Cell Lung · Sponsor: Fudan University

PhaseNA

Planned participants545

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

This is a study from Eastern Cooperative Thoracic Oncology Project, numbered as ECTOP-1009. Systematically mediastinal lymph node dissection or not in clinical stage T1 ground-glass dominated invasive lung adenocarcinoma: a multi-center, prospective clinical trial

This description comes directly from the study's public registry record.

Talk to the study team

Haoxuan Wu, Dr. · 86-13901770461 · haoxuanwu@hotmail.com

Haiquan Chen, Ph.D

Always discuss trial participation with your own doctor first.

Locations (1)

Fudan University Shanghai Cancer Center

Shanghai, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04527419